基本信息
浏览量:23
职业迁徙
个人简介
Dr. Anderson’s research throughout the past 30 years laid a foundation for the growth of radiometal-based agents for diagnostic imaging and targeted radionuclide therapy of cancer, a field now coined “theranostics”. Her lab performed early research on the development of copper-64-labeled antibodies and peptides for positron emission tomography (PET) imaging of cancer, and she and colleagues at Washington University led the first human study of a copper-64-labeled somatostatin analog to image neuroendocrine tumors. The first commercial copper-64-labeled agent in this class is now moving towards FDA approval and commercialization (Cu-64 DOTATATE). Nearly 20 years ago her lab published pre-clinical toxicity of the 177Lu-labeled version of DOTATATE, and that agent is now FDA-approved and commercially available for treating neuroendocrine tumors.
研究兴趣
论文共 471 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Madhushan Serasinghe, Patrick Bokolo, Ritin Kamboj, Jack Lydon,James Guthrie, D. Scott Wilbur,Yawen Li, Dmitri Medvedev,Cathy Cutler,Carolyn Anderson,Silvia Jurisson,Heather Hennkens
Nuclear Medicine and Biology (2023): 108779
Patrick Bokolo, Madhushan Serasinghe, Leonard Manson, Jack Lydon,Mary Embree,Dmitri Medvedev,Cathy Cutler,D. Scott Wilbur,Yawen Li,Carolyn Anderson,Silvia Jurisson,Heather Hennkens
NUCLEAR MEDICINE AND BIOLOGY (2023): S284-S284
NUCLEAR MEDICINE AND BIOLOGY (2023): S302-S302
引用0浏览0引用
0
0
Cyril Fong,Anupam Mathur,Michael Bellavia, Christine Lovingier,Michael Pun, Katherine Tucker,Shubhanchi Nigam,Fabio Gallazzi,Lisa Watkinson,Terry Carmack,David Tatum,Darren Magda,
Michal Nisnboym,Sarah R. Vincze,Zujian Xiong, Chaim T. Sneiderman, Rebecca A. Raphael,Bo Li, Ambika P. Jaswal, ReidAnn E. Sever,Kathryn E. Day,Joseph D. LaToche,Lesley M. Foley, Hanieh Karimi,
crossref(2023)
NUCLEAR MEDICINE AND BIOLOGY (2023): S252-S253
Nuclear Medicine and Biology (2023): 108803
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn